Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6087020 | 0.91 | GRIN1 (0.43) | KMT2AMEN1TDP1GRIN1GRIN2B | |
| SCHEMBL7070169 | 0.89 | KMT2A (0.36) | KMT2AMEN1TDP1GRIN1GRIN2B | |
| SCHEMBL7067487 | 0.89 | GRIN1 (0.39) | KMT2AMEN1TDP1GRIN1GRIN2B | |
| SCHEMBL6087285 | 0.89 | GRIN1 (0.39) | KMT2AMEN1TDP1GRIN1GRIN2B | |
| SCHEMBL6088074 | 0.88 | GRIN1 (0.39) | KMT2AMEN1TDP1GRIN1GRIN2B | |
| SCHEMBL675171 | 0.85 | KMT2A (0.35) | KMT2AMEN1TDP1GRIN1GRIN2B | |
| SCHEMBL13996749 | 0.85 | GAA (0.36) | KMT2AMEN1SMN1; SMN2ALDH1A1 | |
| SCHEMBL6086536 | 0.85 | KMT2A (0.36) | KMT2AMEN1TDP1GRIN1GRIN2B | |
| SCHEMBL3186190 | 0.85 | TSHR (0.36) | KMT2AMEN1SMN1; SMN2ALDH1A1 | |
| SCHEMBL7076081 | 0.83 | GRIN1 (0.34) | KMT2AMEN1TDP1GRIN1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255968-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | KISER PATRICK F (US) | 2025-08-14 | — | — | US | claimed |
| EP-2734262-B1 | INTRAVAGINAL RINGS FOR DRUG DELIVERY | KISER PATRICK F (US) | 2018-02-28 | — | — | EP | claimed |
| US-20140209100-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | Kiser, Patrick F. | 2014-07-31 | — | — | US | claimed |
| EP-2734262-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | Kiser, Patrick F. (US) | 2014-05-28 | — | — | EP | claimed |
| US-20130220337-A1 | DEVICES AND METHODS FOR INTRAVAGINAL DELIVERY OF DRUGS AND OTHER SUBSTANCES | KISER PATRICK F (US) | 2013-08-29 | — | — | US | claimed |
| EP-2605779-A2 | DEVICES AND METHODS FOR INTRAVAGINAL DELIVERY OF DRUGS AND OTHER SUBSTANCES | The University of Utah Research Foundation (US) | 2013-06-26 | — | — | EP | claimed |
| WO-2013013172-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2013-01-24 | — | — | WO | claimed |
| WO-2012024605-A2 | DEVICES AND METHODS FOR INTRAVAGINAL DELIVERY OF DRUGS AND OTHER SUBSTANCES | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2012-02-23 | — | — | WO | claimed |
| US-20110045076-A1 | LINEAR ORDER RELEASE POLYMER | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2011-02-24 | — | — | US | claimed |
| EP-2244782-A2 | LINEAR ORDER RELEASE POLYMER | The University of Utah Research Foundation (US) | 2010-11-03 | — | — | EP | claimed |
| WO-2009094573-A9 | LINEAR ORDER RELEASE POLYMER | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2010-09-16 | — | — | WO | claimed |
| WO-2009094573-A2 | LINEAR ORDER RELEASE POLYMER | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-07-30 | — | — | WO | claimed |
| US-20250255968-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | KISER PATRICK F (US) | 2025-08-14 | — | — | US | disclosed |
| US-20220409589-A1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | GENZYME CORP (US) | 2022-12-29 | — | — | US | disclosed |
| EP-2734262-B1 | INTRAVAGINAL RINGS FOR DRUG DELIVERY | KISER PATRICK F (US) | 2018-02-28 | — | — | EP | disclosed |
| US-20140209100-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | Kiser, Patrick F. | 2014-07-31 | — | — | US | disclosed |
| US-6274732-B1 | ALKYLATION | SAMJIN PHARMACEUTICAL CO., LTD. (KR) | 2001-08-14 | — | — | US | disclosed |
| JP-2000264878-A | PRODUCTION OF 1-[(CYCLOPENT-3-EN-1-YL)METHYL]-5-ETHYL-6-(3,5- DIMETHYLBENZOYL)-2,4-PYRIMIDINEDIONE | SAMJIN PHARMACEUTICAL CO LTD | 2000-09-26 | — | — | JP | disclosed |
| EP-1035116-A1 | Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrimidinedione | Samjin Pharmaceutical Co., Ltd. (KR) | 2000-09-13 | — | — | EP | disclosed |
| US-5922727-A | 1-((SUBSTITUTED)CYCLOALK(EN)YLALKYL)-6-((SUB)PHENYL(CARBONYL, SULFIDE, OR OXO))-2,4-PYRIMIDINEDIONE DERIVATIVES HAVING SUPERIOR ANTIVIRAL ACTIVITIES; HIV | SAMJIN PHARMACEUTICAL CO., LTD (KR) | 1999-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220409589-A1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | CCR5, CXCR4, CXCR3 | KMT2A 3464/4885MEN1 3210/4885TDP1 4428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.